Global Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Global Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Page: 146

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Radiopharmaceuticals market size is expected to reach $ 11660 million by 2030, rising at a market growth of 7.7% CAGR during the forecast period (2024-2030).

The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

This report studies the global Radiopharmaceuticals production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Radiopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceuticals that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Radiopharmaceuticals total production and demand, 2019-2030, (K Units)
Global Radiopharmaceuticals total production value, 2019-2030, (USD Million)
Global Radiopharmaceuticals production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Radiopharmaceuticals consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Radiopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global Radiopharmaceuticals production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Radiopharmaceuticals production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Radiopharmaceuticals production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Radiopharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceuticals market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Radiopharmaceuticals Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Radiopharmaceuticals Market, Segmentation by Type
Diagnostic Radioisotopes
Therapeutic Radioisotopes

Global Radiopharmaceuticals Market, Segmentation by Application
Oncology
Cardiology
Other

Companies Profiled:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

Key Questions Answered
1. How big is the global Radiopharmaceuticals market?
2. What is the demand of the global Radiopharmaceuticals market?
3. What is the year over year growth of the global Radiopharmaceuticals market?
4. What is the production and production value of the global Radiopharmaceuticals market?
5. Who are the key producers in the global Radiopharmaceuticals market?
btl

Table of Contents

1 Supply Summary
1.1 Radiopharmaceuticals Introduction
1.2 World Radiopharmaceuticals Supply & Forecast
1.2.1 World Radiopharmaceuticals Production Value (2019 & 2023 & 2030)
1.2.2 World Radiopharmaceuticals Production (2019-2030)
1.2.3 World Radiopharmaceuticals Pricing Trends (2019-2030)
1.3 World Radiopharmaceuticals Production by Region (Based on Production Site)
1.3.1 World Radiopharmaceuticals Production Value by Region (2019-2030)
1.3.2 World Radiopharmaceuticals Production by Region (2019-2030)
1.3.3 World Radiopharmaceuticals Average Price by Region (2019-2030)
1.3.4 North America Radiopharmaceuticals Production (2019-2030)
1.3.5 Europe Radiopharmaceuticals Production (2019-2030)
1.3.6 China Radiopharmaceuticals Production (2019-2030)
1.3.7 India Radiopharmaceuticals Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radiopharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radiopharmaceuticals Major Market Trends

2 Demand Summary
2.1 World Radiopharmaceuticals Demand (2019-2030)
2.2 World Radiopharmaceuticals Consumption by Region
2.2.1 World Radiopharmaceuticals Consumption by Region (2019-2024)
2.2.2 World Radiopharmaceuticals Consumption Forecast by Region (2025-2030)
2.3 United States Radiopharmaceuticals Consumption (2019-2030)
2.4 China Radiopharmaceuticals Consumption (2019-2030)
2.5 Europe Radiopharmaceuticals Consumption (2019-2030)
2.6 Japan Radiopharmaceuticals Consumption (2019-2030)
2.7 South Korea Radiopharmaceuticals Consumption (2019-2030)
2.8 ASEAN Radiopharmaceuticals Consumption (2019-2030)
2.9 India Radiopharmaceuticals Consumption (2019-2030)

3 World Radiopharmaceuticals Manufacturers Competitive Analysis
3.1 World Radiopharmaceuticals Production Value by Manufacturer (2019-2024)
3.2 World Radiopharmaceuticals Production by Manufacturer (2019-2024)
3.3 World Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
3.4 Radiopharmaceuticals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Radiopharmaceuticals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Radiopharmaceuticals in 2023
3.5.3 Global Concentration Ratios (CR8) for Radiopharmaceuticals in 2023
3.6 Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.6.1 Radiopharmaceuticals Market: Region Footprint
3.6.2 Radiopharmaceuticals Market: Company Product Type Footprint
3.6.3 Radiopharmaceuticals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Radiopharmaceuticals Production Value Comparison
4.1.1 United States VS China: Radiopharmaceuticals Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Radiopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Radiopharmaceuticals Production Comparison
4.2.1 United States VS China: Radiopharmaceuticals Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Radiopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Radiopharmaceuticals Consumption Comparison
4.3.1 United States VS China: Radiopharmaceuticals Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Radiopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Radiopharmaceuticals Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Radiopharmaceuticals Production Value (2019-2024)
4.4.3 United States Based Manufacturers Radiopharmaceuticals Production (2019-2024)
4.5 China Based Radiopharmaceuticals Manufacturers and Market Share
4.5.1 China Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Radiopharmaceuticals Production Value (2019-2024)
4.5.3 China Based Manufacturers Radiopharmaceuticals Production (2019-2024)
4.6 Rest of World Based Radiopharmaceuticals Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Radiopharmaceuticals Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Radiopharmaceuticals Production (2019-2024)

5 Market Analysis by Type
5.1 World Radiopharmaceuticals Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Diagnostic Radioisotopes
5.2.2 Therapeutic Radioisotopes
5.3 Market Segment by Type
5.3.1 World Radiopharmaceuticals Production by Type (2019-2030)
5.3.2 World Radiopharmaceuticals Production Value by Type (2019-2030)
5.3.3 World Radiopharmaceuticals Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Radiopharmaceuticals Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Radiopharmaceuticals Production by Application (2019-2030)
6.3.2 World Radiopharmaceuticals Production Value by Application (2019-2030)
6.3.3 World Radiopharmaceuticals Average Price by Application (2019-2030)

7 Company Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Details
7.1.2 Bracco Imaging Major Business
7.1.3 Bracco Imaging Radiopharmaceuticals Product and Services
7.1.4 Bracco Imaging Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Bracco Imaging Recent Developments/Updates
7.1.6 Bracco Imaging Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Radiopharmaceuticals Product and Services
7.2.4 Bayer Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Mallinckrodt
7.3.1 Mallinckrodt Details
7.3.2 Mallinckrodt Major Business
7.3.3 Mallinckrodt Radiopharmaceuticals Product and Services
7.3.4 Mallinckrodt Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Mallinckrodt Recent Developments/Updates
7.3.6 Mallinckrodt Competitive Strengths & Weaknesses
7.4 Nordion
7.4.1 Nordion Details
7.4.2 Nordion Major Business
7.4.3 Nordion Radiopharmaceuticals Product and Services
7.4.4 Nordion Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Nordion Recent Developments/Updates
7.4.6 Nordion Competitive Strengths & Weaknesses
7.5 Triad Isotopes
7.5.1 Triad Isotopes Details
7.5.2 Triad Isotopes Major Business
7.5.3 Triad Isotopes Radiopharmaceuticals Product and Services
7.5.4 Triad Isotopes Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Triad Isotopes Recent Developments/Updates
7.5.6 Triad Isotopes Competitive Strengths & Weaknesses
7.6 Lantheus
7.6.1 Lantheus Details
7.6.2 Lantheus Major Business
7.6.3 Lantheus Radiopharmaceuticals Product and Services
7.6.4 Lantheus Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Lantheus Recent Developments/Updates
7.6.6 Lantheus Competitive Strengths & Weaknesses
7.7 IBA Group
7.7.1 IBA Group Details
7.7.2 IBA Group Major Business
7.7.3 IBA Group Radiopharmaceuticals Product and Services
7.7.4 IBA Group Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 IBA Group Recent Developments/Updates
7.7.6 IBA Group Competitive Strengths & Weaknesses
7.8 GE Healthcare
7.8.1 GE Healthcare Details
7.8.2 GE Healthcare Major Business
7.8.3 GE Healthcare Radiopharmaceuticals Product and Services
7.8.4 GE Healthcare Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 GE Healthcare Recent Developments/Updates
7.8.6 GE Healthcare Competitive Strengths & Weaknesses
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Details
7.9.2 China Isotope & Radiation Major Business
7.9.3 China Isotope & Radiation Radiopharmaceuticals Product and Services
7.9.4 China Isotope & Radiation Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 China Isotope & Radiation Recent Developments/Updates
7.9.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Details
7.10.2 Jubilant Pharma Major Business
7.10.3 Jubilant Pharma Radiopharmaceuticals Product and Services
7.10.4 Jubilant Pharma Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Jubilant Pharma Recent Developments/Updates
7.10.6 Jubilant Pharma Competitive Strengths & Weaknesses
7.11 Eli Lilly
7.11.1 Eli Lilly Details
7.11.2 Eli Lilly Major Business
7.11.3 Eli Lilly Radiopharmaceuticals Product and Services
7.11.4 Eli Lilly Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Eli Lilly Recent Developments/Updates
7.11.6 Eli Lilly Competitive Strengths & Weaknesses
7.12 Advanced Accelerator Applications
7.12.1 Advanced Accelerator Applications Details
7.12.2 Advanced Accelerator Applications Major Business
7.12.3 Advanced Accelerator Applications Radiopharmaceuticals Product and Services
7.12.4 Advanced Accelerator Applications Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Advanced Accelerator Applications Recent Developments/Updates
7.12.6 Advanced Accelerator Applications Competitive Strengths & Weaknesses
7.13 SIEMENS
7.13.1 SIEMENS Details
7.13.2 SIEMENS Major Business
7.13.3 SIEMENS Radiopharmaceuticals Product and Services
7.13.4 SIEMENS Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 SIEMENS Recent Developments/Updates
7.13.6 SIEMENS Competitive Strengths & Weaknesses
7.14 Dongcheng
7.14.1 Dongcheng Details
7.14.2 Dongcheng Major Business
7.14.3 Dongcheng Radiopharmaceuticals Product and Services
7.14.4 Dongcheng Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Dongcheng Recent Developments/Updates
7.14.6 Dongcheng Competitive Strengths & Weaknesses
7.15 Navidea
7.15.1 Navidea Details
7.15.2 Navidea Major Business
7.15.3 Navidea Radiopharmaceuticals Product and Services
7.15.4 Navidea Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Navidea Recent Developments/Updates
7.15.6 Navidea Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Radiopharmaceuticals Industry Chain
8.2 Radiopharmaceuticals Upstream Analysis
8.2.1 Radiopharmaceuticals Core Raw Materials
8.2.2 Main Manufacturers of Radiopharmaceuticals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Radiopharmaceuticals Production Mode
8.6 Radiopharmaceuticals Procurement Model
8.7 Radiopharmaceuticals Industry Sales Model and Sales Channels
8.7.1 Radiopharmaceuticals Sales Model
8.7.2 Radiopharmaceuticals Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Radiopharmaceuticals Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Radiopharmaceuticals Production Value by Region (2019-2024) & (USD Million)
Table 3. World Radiopharmaceuticals Production Value by Region (2025-2030) & (USD Million)
Table 4. World Radiopharmaceuticals Production Value Market Share by Region (2019-2024)
Table 5. World Radiopharmaceuticals Production Value Market Share by Region (2025-2030)
Table 6. World Radiopharmaceuticals Production by Region (2019-2024) & (K Units)
Table 7. World Radiopharmaceuticals Production by Region (2025-2030) & (K Units)
Table 8. World Radiopharmaceuticals Production Market Share by Region (2019-2024)
Table 9. World Radiopharmaceuticals Production Market Share by Region (2025-2030)
Table 10. World Radiopharmaceuticals Average Price by Region (2019-2024) & (USD/Unit)
Table 11. World Radiopharmaceuticals Average Price by Region (2025-2030) & (USD/Unit)
Table 12. Radiopharmaceuticals Major Market Trends
Table 13. World Radiopharmaceuticals Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Radiopharmaceuticals Consumption by Region (2019-2024) & (K Units)
Table 15. World Radiopharmaceuticals Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Radiopharmaceuticals Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Radiopharmaceuticals Producers in 2023
Table 18. World Radiopharmaceuticals Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Radiopharmaceuticals Producers in 2023
Table 20. World Radiopharmaceuticals Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Global Radiopharmaceuticals Company Evaluation Quadrant
Table 22. World Radiopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Radiopharmaceuticals Production Site of Key Manufacturer
Table 24. Radiopharmaceuticals Market: Company Product Type Footprint
Table 25. Radiopharmaceuticals Market: Company Product Application Footprint
Table 26. Radiopharmaceuticals Competitive Factors
Table 27. Radiopharmaceuticals New Entrant and Capacity Expansion Plans
Table 28. Radiopharmaceuticals Mergers & Acquisitions Activity
Table 29. United States VS China Radiopharmaceuticals Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Radiopharmaceuticals Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Radiopharmaceuticals Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Radiopharmaceuticals Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Radiopharmaceuticals Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Radiopharmaceuticals Production Market Share (2019-2024)
Table 37. China Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Radiopharmaceuticals Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Radiopharmaceuticals Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Radiopharmaceuticals Production Market Share (2019-2024)
Table 42. Rest of World Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Radiopharmaceuticals Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Radiopharmaceuticals Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Radiopharmaceuticals Production Market Share (2019-2024)
Table 47. World Radiopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Radiopharmaceuticals Production by Type (2019-2024) & (K Units)
Table 49. World Radiopharmaceuticals Production by Type (2025-2030) & (K Units)
Table 50. World Radiopharmaceuticals Production Value by Type (2019-2024) & (USD Million)
Table 51. World Radiopharmaceuticals Production Value by Type (2025-2030) & (USD Million)
Table 52. World Radiopharmaceuticals Average Price by Type (2019-2024) & (USD/Unit)
Table 53. World Radiopharmaceuticals Average Price by Type (2025-2030) & (USD/Unit)
Table 54. World Radiopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Radiopharmaceuticals Production by Application (2019-2024) & (K Units)
Table 56. World Radiopharmaceuticals Production by Application (2025-2030) & (K Units)
Table 57. World Radiopharmaceuticals Production Value by Application (2019-2024) & (USD Million)
Table 58. World Radiopharmaceuticals Production Value by Application (2025-2030) & (USD Million)
Table 59. World Radiopharmaceuticals Average Price by Application (2019-2024) & (USD/Unit)
Table 60. World Radiopharmaceuticals Average Price by Application (2025-2030) & (USD/Unit)
Table 61. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 62. Bracco Imaging Major Business
Table 63. Bracco Imaging Radiopharmaceuticals Product and Services
Table 64. Bracco Imaging Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Bracco Imaging Recent Developments/Updates
Table 66. Bracco Imaging Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Radiopharmaceuticals Product and Services
Table 70. Bayer Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 74. Mallinckrodt Major Business
Table 75. Mallinckrodt Radiopharmaceuticals Product and Services
Table 76. Mallinckrodt Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Mallinckrodt Recent Developments/Updates
Table 78. Mallinckrodt Competitive Strengths & Weaknesses
Table 79. Nordion Basic Information, Manufacturing Base and Competitors
Table 80. Nordion Major Business
Table 81. Nordion Radiopharmaceuticals Product and Services
Table 82. Nordion Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Nordion Recent Developments/Updates
Table 84. Nordion Competitive Strengths & Weaknesses
Table 85. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 86. Triad Isotopes Major Business
Table 87. Triad Isotopes Radiopharmaceuticals Product and Services
Table 88. Triad Isotopes Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Triad Isotopes Recent Developments/Updates
Table 90. Triad Isotopes Competitive Strengths & Weaknesses
Table 91. Lantheus Basic Information, Manufacturing Base and Competitors
Table 92. Lantheus Major Business
Table 93. Lantheus Radiopharmaceuticals Product and Services
Table 94. Lantheus Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Lantheus Recent Developments/Updates
Table 96. Lantheus Competitive Strengths & Weaknesses
Table 97. IBA Group Basic Information, Manufacturing Base and Competitors
Table 98. IBA Group Major Business
Table 99. IBA Group Radiopharmaceuticals Product and Services
Table 100. IBA Group Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. IBA Group Recent Developments/Updates
Table 102. IBA Group Competitive Strengths & Weaknesses
Table 103. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. GE Healthcare Major Business
Table 105. GE Healthcare Radiopharmaceuticals Product and Services
Table 106. GE Healthcare Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. GE Healthcare Recent Developments/Updates
Table 108. GE Healthcare Competitive Strengths & Weaknesses
Table 109. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 110. China Isotope & Radiation Major Business
Table 111. China Isotope & Radiation Radiopharmaceuticals Product and Services
Table 112. China Isotope & Radiation Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. China Isotope & Radiation Recent Developments/Updates
Table 114. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 115. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 116. Jubilant Pharma Major Business
Table 117. Jubilant Pharma Radiopharmaceuticals Product and Services
Table 118. Jubilant Pharma Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Jubilant Pharma Recent Developments/Updates
Table 120. Jubilant Pharma Competitive Strengths & Weaknesses
Table 121. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 122. Eli Lilly Major Business
Table 123. Eli Lilly Radiopharmaceuticals Product and Services
Table 124. Eli Lilly Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Eli Lilly Recent Developments/Updates
Table 126. Eli Lilly Competitive Strengths & Weaknesses
Table 127. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 128. Advanced Accelerator Applications Major Business
Table 129. Advanced Accelerator Applications Radiopharmaceuticals Product and Services
Table 130. Advanced Accelerator Applications Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Advanced Accelerator Applications Recent Developments/Updates
Table 132. Advanced Accelerator Applications Competitive Strengths & Weaknesses
Table 133. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 134. SIEMENS Major Business
Table 135. SIEMENS Radiopharmaceuticals Product and Services
Table 136. SIEMENS Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. SIEMENS Recent Developments/Updates
Table 138. SIEMENS Competitive Strengths & Weaknesses
Table 139. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 140. Dongcheng Major Business
Table 141. Dongcheng Radiopharmaceuticals Product and Services
Table 142. Dongcheng Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Dongcheng Recent Developments/Updates
Table 144. Navidea Basic Information, Manufacturing Base and Competitors
Table 145. Navidea Major Business
Table 146. Navidea Radiopharmaceuticals Product and Services
Table 147. Navidea Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 148. Global Key Players of Radiopharmaceuticals Upstream (Raw Materials)
Table 149. Radiopharmaceuticals Typical Customers
Table 150. Radiopharmaceuticals Typical Distributors
List of Figure
Figure 1. Radiopharmaceuticals Picture
Figure 2. World Radiopharmaceuticals Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Radiopharmaceuticals Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Radiopharmaceuticals Production (2019-2030) & (K Units)
Figure 5. World Radiopharmaceuticals Average Price (2019-2030) & (USD/Unit)
Figure 6. World Radiopharmaceuticals Production Value Market Share by Region (2019-2030)
Figure 7. World Radiopharmaceuticals Production Market Share by Region (2019-2030)
Figure 8. North America Radiopharmaceuticals Production (2019-2030) & (K Units)
Figure 9. Europe Radiopharmaceuticals Production (2019-2030) & (K Units)
Figure 10. China Radiopharmaceuticals Production (2019-2030) & (K Units)
Figure 11. India Radiopharmaceuticals Production (2019-2030) & (K Units)
Figure 12. Radiopharmaceuticals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 15. World Radiopharmaceuticals Consumption Market Share by Region (2019-2030)
Figure 16. United States Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 17. China Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 18. Europe Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 19. Japan Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 20. South Korea Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 22. India Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceuticals Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceuticals Markets in 2023
Figure 26. United States VS China: Radiopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Radiopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Radiopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Radiopharmaceuticals Production Market Share 2023
Figure 30. China Based Manufacturers Radiopharmaceuticals Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Radiopharmaceuticals Production Market Share 2023
Figure 32. World Radiopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Radiopharmaceuticals Production Value Market Share by Type in 2023
Figure 34. Diagnostic Radioisotopes
Figure 35. Therapeutic Radioisotopes
Figure 36. World Radiopharmaceuticals Production Market Share by Type (2019-2030)
Figure 37. World Radiopharmaceuticals Production Value Market Share by Type (2019-2030)
Figure 38. World Radiopharmaceuticals Average Price by Type (2019-2030) & (USD/Unit)
Figure 39. World Radiopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Radiopharmaceuticals Production Value Market Share by Application in 2023
Figure 41. Oncology
Figure 42. Cardiology
Figure 43. Other
Figure 44. World Radiopharmaceuticals Production Market Share by Application (2019-2030)
Figure 45. World Radiopharmaceuticals Production Value Market Share by Application (2019-2030)
Figure 46. World Radiopharmaceuticals Average Price by Application (2019-2030) & (USD/Unit)
Figure 47. Radiopharmaceuticals Industry Chain
Figure 48. Radiopharmaceuticals Procurement Model
Figure 49. Radiopharmaceuticals Sales Model
Figure 50. Radiopharmaceuticals Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Global Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Page: 146

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Radiopharmaceuticals market size is expected to reach $ 11660 million by 2030, rising at a market growth of 7.7% CAGR during the forecast period (2024-2030).

The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

This report studies the global Radiopharmaceuticals production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Radiopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceuticals that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Radiopharmaceuticals total production and demand, 2019-2030, (K Units)
Global Radiopharmaceuticals total production value, 2019-2030, (USD Million)
Global Radiopharmaceuticals production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Radiopharmaceuticals consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Radiopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global Radiopharmaceuticals production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Radiopharmaceuticals production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Radiopharmaceuticals production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Radiopharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceuticals market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Radiopharmaceuticals Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Radiopharmaceuticals Market, Segmentation by Type
Diagnostic Radioisotopes
Therapeutic Radioisotopes

Global Radiopharmaceuticals Market, Segmentation by Application
Oncology
Cardiology
Other

Companies Profiled:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

Key Questions Answered
1. How big is the global Radiopharmaceuticals market?
2. What is the demand of the global Radiopharmaceuticals market?
3. What is the year over year growth of the global Radiopharmaceuticals market?
4. What is the production and production value of the global Radiopharmaceuticals market?
5. Who are the key producers in the global Radiopharmaceuticals market?
btl

Table of Contents

1 Supply Summary
1.1 Radiopharmaceuticals Introduction
1.2 World Radiopharmaceuticals Supply & Forecast
1.2.1 World Radiopharmaceuticals Production Value (2019 & 2023 & 2030)
1.2.2 World Radiopharmaceuticals Production (2019-2030)
1.2.3 World Radiopharmaceuticals Pricing Trends (2019-2030)
1.3 World Radiopharmaceuticals Production by Region (Based on Production Site)
1.3.1 World Radiopharmaceuticals Production Value by Region (2019-2030)
1.3.2 World Radiopharmaceuticals Production by Region (2019-2030)
1.3.3 World Radiopharmaceuticals Average Price by Region (2019-2030)
1.3.4 North America Radiopharmaceuticals Production (2019-2030)
1.3.5 Europe Radiopharmaceuticals Production (2019-2030)
1.3.6 China Radiopharmaceuticals Production (2019-2030)
1.3.7 India Radiopharmaceuticals Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radiopharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radiopharmaceuticals Major Market Trends

2 Demand Summary
2.1 World Radiopharmaceuticals Demand (2019-2030)
2.2 World Radiopharmaceuticals Consumption by Region
2.2.1 World Radiopharmaceuticals Consumption by Region (2019-2024)
2.2.2 World Radiopharmaceuticals Consumption Forecast by Region (2025-2030)
2.3 United States Radiopharmaceuticals Consumption (2019-2030)
2.4 China Radiopharmaceuticals Consumption (2019-2030)
2.5 Europe Radiopharmaceuticals Consumption (2019-2030)
2.6 Japan Radiopharmaceuticals Consumption (2019-2030)
2.7 South Korea Radiopharmaceuticals Consumption (2019-2030)
2.8 ASEAN Radiopharmaceuticals Consumption (2019-2030)
2.9 India Radiopharmaceuticals Consumption (2019-2030)

3 World Radiopharmaceuticals Manufacturers Competitive Analysis
3.1 World Radiopharmaceuticals Production Value by Manufacturer (2019-2024)
3.2 World Radiopharmaceuticals Production by Manufacturer (2019-2024)
3.3 World Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
3.4 Radiopharmaceuticals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Radiopharmaceuticals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Radiopharmaceuticals in 2023
3.5.3 Global Concentration Ratios (CR8) for Radiopharmaceuticals in 2023
3.6 Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.6.1 Radiopharmaceuticals Market: Region Footprint
3.6.2 Radiopharmaceuticals Market: Company Product Type Footprint
3.6.3 Radiopharmaceuticals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Radiopharmaceuticals Production Value Comparison
4.1.1 United States VS China: Radiopharmaceuticals Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Radiopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Radiopharmaceuticals Production Comparison
4.2.1 United States VS China: Radiopharmaceuticals Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Radiopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Radiopharmaceuticals Consumption Comparison
4.3.1 United States VS China: Radiopharmaceuticals Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Radiopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Radiopharmaceuticals Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Radiopharmaceuticals Production Value (2019-2024)
4.4.3 United States Based Manufacturers Radiopharmaceuticals Production (2019-2024)
4.5 China Based Radiopharmaceuticals Manufacturers and Market Share
4.5.1 China Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Radiopharmaceuticals Production Value (2019-2024)
4.5.3 China Based Manufacturers Radiopharmaceuticals Production (2019-2024)
4.6 Rest of World Based Radiopharmaceuticals Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Radiopharmaceuticals Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Radiopharmaceuticals Production (2019-2024)

5 Market Analysis by Type
5.1 World Radiopharmaceuticals Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Diagnostic Radioisotopes
5.2.2 Therapeutic Radioisotopes
5.3 Market Segment by Type
5.3.1 World Radiopharmaceuticals Production by Type (2019-2030)
5.3.2 World Radiopharmaceuticals Production Value by Type (2019-2030)
5.3.3 World Radiopharmaceuticals Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Radiopharmaceuticals Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Radiopharmaceuticals Production by Application (2019-2030)
6.3.2 World Radiopharmaceuticals Production Value by Application (2019-2030)
6.3.3 World Radiopharmaceuticals Average Price by Application (2019-2030)

7 Company Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Details
7.1.2 Bracco Imaging Major Business
7.1.3 Bracco Imaging Radiopharmaceuticals Product and Services
7.1.4 Bracco Imaging Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Bracco Imaging Recent Developments/Updates
7.1.6 Bracco Imaging Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Radiopharmaceuticals Product and Services
7.2.4 Bayer Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Mallinckrodt
7.3.1 Mallinckrodt Details
7.3.2 Mallinckrodt Major Business
7.3.3 Mallinckrodt Radiopharmaceuticals Product and Services
7.3.4 Mallinckrodt Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Mallinckrodt Recent Developments/Updates
7.3.6 Mallinckrodt Competitive Strengths & Weaknesses
7.4 Nordion
7.4.1 Nordion Details
7.4.2 Nordion Major Business
7.4.3 Nordion Radiopharmaceuticals Product and Services
7.4.4 Nordion Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Nordion Recent Developments/Updates
7.4.6 Nordion Competitive Strengths & Weaknesses
7.5 Triad Isotopes
7.5.1 Triad Isotopes Details
7.5.2 Triad Isotopes Major Business
7.5.3 Triad Isotopes Radiopharmaceuticals Product and Services
7.5.4 Triad Isotopes Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Triad Isotopes Recent Developments/Updates
7.5.6 Triad Isotopes Competitive Strengths & Weaknesses
7.6 Lantheus
7.6.1 Lantheus Details
7.6.2 Lantheus Major Business
7.6.3 Lantheus Radiopharmaceuticals Product and Services
7.6.4 Lantheus Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Lantheus Recent Developments/Updates
7.6.6 Lantheus Competitive Strengths & Weaknesses
7.7 IBA Group
7.7.1 IBA Group Details
7.7.2 IBA Group Major Business
7.7.3 IBA Group Radiopharmaceuticals Product and Services
7.7.4 IBA Group Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 IBA Group Recent Developments/Updates
7.7.6 IBA Group Competitive Strengths & Weaknesses
7.8 GE Healthcare
7.8.1 GE Healthcare Details
7.8.2 GE Healthcare Major Business
7.8.3 GE Healthcare Radiopharmaceuticals Product and Services
7.8.4 GE Healthcare Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 GE Healthcare Recent Developments/Updates
7.8.6 GE Healthcare Competitive Strengths & Weaknesses
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Details
7.9.2 China Isotope & Radiation Major Business
7.9.3 China Isotope & Radiation Radiopharmaceuticals Product and Services
7.9.4 China Isotope & Radiation Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 China Isotope & Radiation Recent Developments/Updates
7.9.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Details
7.10.2 Jubilant Pharma Major Business
7.10.3 Jubilant Pharma Radiopharmaceuticals Product and Services
7.10.4 Jubilant Pharma Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Jubilant Pharma Recent Developments/Updates
7.10.6 Jubilant Pharma Competitive Strengths & Weaknesses
7.11 Eli Lilly
7.11.1 Eli Lilly Details
7.11.2 Eli Lilly Major Business
7.11.3 Eli Lilly Radiopharmaceuticals Product and Services
7.11.4 Eli Lilly Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Eli Lilly Recent Developments/Updates
7.11.6 Eli Lilly Competitive Strengths & Weaknesses
7.12 Advanced Accelerator Applications
7.12.1 Advanced Accelerator Applications Details
7.12.2 Advanced Accelerator Applications Major Business
7.12.3 Advanced Accelerator Applications Radiopharmaceuticals Product and Services
7.12.4 Advanced Accelerator Applications Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Advanced Accelerator Applications Recent Developments/Updates
7.12.6 Advanced Accelerator Applications Competitive Strengths & Weaknesses
7.13 SIEMENS
7.13.1 SIEMENS Details
7.13.2 SIEMENS Major Business
7.13.3 SIEMENS Radiopharmaceuticals Product and Services
7.13.4 SIEMENS Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 SIEMENS Recent Developments/Updates
7.13.6 SIEMENS Competitive Strengths & Weaknesses
7.14 Dongcheng
7.14.1 Dongcheng Details
7.14.2 Dongcheng Major Business
7.14.3 Dongcheng Radiopharmaceuticals Product and Services
7.14.4 Dongcheng Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Dongcheng Recent Developments/Updates
7.14.6 Dongcheng Competitive Strengths & Weaknesses
7.15 Navidea
7.15.1 Navidea Details
7.15.2 Navidea Major Business
7.15.3 Navidea Radiopharmaceuticals Product and Services
7.15.4 Navidea Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Navidea Recent Developments/Updates
7.15.6 Navidea Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Radiopharmaceuticals Industry Chain
8.2 Radiopharmaceuticals Upstream Analysis
8.2.1 Radiopharmaceuticals Core Raw Materials
8.2.2 Main Manufacturers of Radiopharmaceuticals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Radiopharmaceuticals Production Mode
8.6 Radiopharmaceuticals Procurement Model
8.7 Radiopharmaceuticals Industry Sales Model and Sales Channels
8.7.1 Radiopharmaceuticals Sales Model
8.7.2 Radiopharmaceuticals Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Radiopharmaceuticals Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Radiopharmaceuticals Production Value by Region (2019-2024) & (USD Million)
Table 3. World Radiopharmaceuticals Production Value by Region (2025-2030) & (USD Million)
Table 4. World Radiopharmaceuticals Production Value Market Share by Region (2019-2024)
Table 5. World Radiopharmaceuticals Production Value Market Share by Region (2025-2030)
Table 6. World Radiopharmaceuticals Production by Region (2019-2024) & (K Units)
Table 7. World Radiopharmaceuticals Production by Region (2025-2030) & (K Units)
Table 8. World Radiopharmaceuticals Production Market Share by Region (2019-2024)
Table 9. World Radiopharmaceuticals Production Market Share by Region (2025-2030)
Table 10. World Radiopharmaceuticals Average Price by Region (2019-2024) & (USD/Unit)
Table 11. World Radiopharmaceuticals Average Price by Region (2025-2030) & (USD/Unit)
Table 12. Radiopharmaceuticals Major Market Trends
Table 13. World Radiopharmaceuticals Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Radiopharmaceuticals Consumption by Region (2019-2024) & (K Units)
Table 15. World Radiopharmaceuticals Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Radiopharmaceuticals Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Radiopharmaceuticals Producers in 2023
Table 18. World Radiopharmaceuticals Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Radiopharmaceuticals Producers in 2023
Table 20. World Radiopharmaceuticals Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Global Radiopharmaceuticals Company Evaluation Quadrant
Table 22. World Radiopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Radiopharmaceuticals Production Site of Key Manufacturer
Table 24. Radiopharmaceuticals Market: Company Product Type Footprint
Table 25. Radiopharmaceuticals Market: Company Product Application Footprint
Table 26. Radiopharmaceuticals Competitive Factors
Table 27. Radiopharmaceuticals New Entrant and Capacity Expansion Plans
Table 28. Radiopharmaceuticals Mergers & Acquisitions Activity
Table 29. United States VS China Radiopharmaceuticals Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Radiopharmaceuticals Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Radiopharmaceuticals Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Radiopharmaceuticals Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Radiopharmaceuticals Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Radiopharmaceuticals Production Market Share (2019-2024)
Table 37. China Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Radiopharmaceuticals Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Radiopharmaceuticals Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Radiopharmaceuticals Production Market Share (2019-2024)
Table 42. Rest of World Based Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Radiopharmaceuticals Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Radiopharmaceuticals Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Radiopharmaceuticals Production Market Share (2019-2024)
Table 47. World Radiopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Radiopharmaceuticals Production by Type (2019-2024) & (K Units)
Table 49. World Radiopharmaceuticals Production by Type (2025-2030) & (K Units)
Table 50. World Radiopharmaceuticals Production Value by Type (2019-2024) & (USD Million)
Table 51. World Radiopharmaceuticals Production Value by Type (2025-2030) & (USD Million)
Table 52. World Radiopharmaceuticals Average Price by Type (2019-2024) & (USD/Unit)
Table 53. World Radiopharmaceuticals Average Price by Type (2025-2030) & (USD/Unit)
Table 54. World Radiopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Radiopharmaceuticals Production by Application (2019-2024) & (K Units)
Table 56. World Radiopharmaceuticals Production by Application (2025-2030) & (K Units)
Table 57. World Radiopharmaceuticals Production Value by Application (2019-2024) & (USD Million)
Table 58. World Radiopharmaceuticals Production Value by Application (2025-2030) & (USD Million)
Table 59. World Radiopharmaceuticals Average Price by Application (2019-2024) & (USD/Unit)
Table 60. World Radiopharmaceuticals Average Price by Application (2025-2030) & (USD/Unit)
Table 61. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 62. Bracco Imaging Major Business
Table 63. Bracco Imaging Radiopharmaceuticals Product and Services
Table 64. Bracco Imaging Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Bracco Imaging Recent Developments/Updates
Table 66. Bracco Imaging Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Radiopharmaceuticals Product and Services
Table 70. Bayer Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 74. Mallinckrodt Major Business
Table 75. Mallinckrodt Radiopharmaceuticals Product and Services
Table 76. Mallinckrodt Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Mallinckrodt Recent Developments/Updates
Table 78. Mallinckrodt Competitive Strengths & Weaknesses
Table 79. Nordion Basic Information, Manufacturing Base and Competitors
Table 80. Nordion Major Business
Table 81. Nordion Radiopharmaceuticals Product and Services
Table 82. Nordion Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Nordion Recent Developments/Updates
Table 84. Nordion Competitive Strengths & Weaknesses
Table 85. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 86. Triad Isotopes Major Business
Table 87. Triad Isotopes Radiopharmaceuticals Product and Services
Table 88. Triad Isotopes Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Triad Isotopes Recent Developments/Updates
Table 90. Triad Isotopes Competitive Strengths & Weaknesses
Table 91. Lantheus Basic Information, Manufacturing Base and Competitors
Table 92. Lantheus Major Business
Table 93. Lantheus Radiopharmaceuticals Product and Services
Table 94. Lantheus Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Lantheus Recent Developments/Updates
Table 96. Lantheus Competitive Strengths & Weaknesses
Table 97. IBA Group Basic Information, Manufacturing Base and Competitors
Table 98. IBA Group Major Business
Table 99. IBA Group Radiopharmaceuticals Product and Services
Table 100. IBA Group Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. IBA Group Recent Developments/Updates
Table 102. IBA Group Competitive Strengths & Weaknesses
Table 103. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. GE Healthcare Major Business
Table 105. GE Healthcare Radiopharmaceuticals Product and Services
Table 106. GE Healthcare Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. GE Healthcare Recent Developments/Updates
Table 108. GE Healthcare Competitive Strengths & Weaknesses
Table 109. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 110. China Isotope & Radiation Major Business
Table 111. China Isotope & Radiation Radiopharmaceuticals Product and Services
Table 112. China Isotope & Radiation Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. China Isotope & Radiation Recent Developments/Updates
Table 114. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 115. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 116. Jubilant Pharma Major Business
Table 117. Jubilant Pharma Radiopharmaceuticals Product and Services
Table 118. Jubilant Pharma Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Jubilant Pharma Recent Developments/Updates
Table 120. Jubilant Pharma Competitive Strengths & Weaknesses
Table 121. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 122. Eli Lilly Major Business
Table 123. Eli Lilly Radiopharmaceuticals Product and Services
Table 124. Eli Lilly Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Eli Lilly Recent Developments/Updates
Table 126. Eli Lilly Competitive Strengths & Weaknesses
Table 127. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 128. Advanced Accelerator Applications Major Business
Table 129. Advanced Accelerator Applications Radiopharmaceuticals Product and Services
Table 130. Advanced Accelerator Applications Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Advanced Accelerator Applications Recent Developments/Updates
Table 132. Advanced Accelerator Applications Competitive Strengths & Weaknesses
Table 133. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 134. SIEMENS Major Business
Table 135. SIEMENS Radiopharmaceuticals Product and Services
Table 136. SIEMENS Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. SIEMENS Recent Developments/Updates
Table 138. SIEMENS Competitive Strengths & Weaknesses
Table 139. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 140. Dongcheng Major Business
Table 141. Dongcheng Radiopharmaceuticals Product and Services
Table 142. Dongcheng Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Dongcheng Recent Developments/Updates
Table 144. Navidea Basic Information, Manufacturing Base and Competitors
Table 145. Navidea Major Business
Table 146. Navidea Radiopharmaceuticals Product and Services
Table 147. Navidea Radiopharmaceuticals Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 148. Global Key Players of Radiopharmaceuticals Upstream (Raw Materials)
Table 149. Radiopharmaceuticals Typical Customers
Table 150. Radiopharmaceuticals Typical Distributors
List of Figure
Figure 1. Radiopharmaceuticals Picture
Figure 2. World Radiopharmaceuticals Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Radiopharmaceuticals Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Radiopharmaceuticals Production (2019-2030) & (K Units)
Figure 5. World Radiopharmaceuticals Average Price (2019-2030) & (USD/Unit)
Figure 6. World Radiopharmaceuticals Production Value Market Share by Region (2019-2030)
Figure 7. World Radiopharmaceuticals Production Market Share by Region (2019-2030)
Figure 8. North America Radiopharmaceuticals Production (2019-2030) & (K Units)
Figure 9. Europe Radiopharmaceuticals Production (2019-2030) & (K Units)
Figure 10. China Radiopharmaceuticals Production (2019-2030) & (K Units)
Figure 11. India Radiopharmaceuticals Production (2019-2030) & (K Units)
Figure 12. Radiopharmaceuticals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 15. World Radiopharmaceuticals Consumption Market Share by Region (2019-2030)
Figure 16. United States Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 17. China Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 18. Europe Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 19. Japan Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 20. South Korea Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 22. India Radiopharmaceuticals Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceuticals Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceuticals Markets in 2023
Figure 26. United States VS China: Radiopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Radiopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Radiopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Radiopharmaceuticals Production Market Share 2023
Figure 30. China Based Manufacturers Radiopharmaceuticals Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Radiopharmaceuticals Production Market Share 2023
Figure 32. World Radiopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Radiopharmaceuticals Production Value Market Share by Type in 2023
Figure 34. Diagnostic Radioisotopes
Figure 35. Therapeutic Radioisotopes
Figure 36. World Radiopharmaceuticals Production Market Share by Type (2019-2030)
Figure 37. World Radiopharmaceuticals Production Value Market Share by Type (2019-2030)
Figure 38. World Radiopharmaceuticals Average Price by Type (2019-2030) & (USD/Unit)
Figure 39. World Radiopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Radiopharmaceuticals Production Value Market Share by Application in 2023
Figure 41. Oncology
Figure 42. Cardiology
Figure 43. Other
Figure 44. World Radiopharmaceuticals Production Market Share by Application (2019-2030)
Figure 45. World Radiopharmaceuticals Production Value Market Share by Application (2019-2030)
Figure 46. World Radiopharmaceuticals Average Price by Application (2019-2030) & (USD/Unit)
Figure 47. Radiopharmaceuticals Industry Chain
Figure 48. Radiopharmaceuticals Procurement Model
Figure 49. Radiopharmaceuticals Sales Model
Figure 50. Radiopharmaceuticals Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
jiaGou

Add To Cart

gouMai

Buy Now